Kangqiao Capital

CBC Group, formerly known as C-Bridge Capital, is a leading healthcare-dedicated asset management firm headquartered in Singapore. The firm is distinguished by its "invest-to-build" strategy, which involves actively incubating and scaling healthcare companies to address significant unmet medical needs, particularly in Greater China and across Asia. CBC Group focuses on four core sectors: pharmaceuticals, medical technology, healthcare services, and digital health. Through its hands-on operational approach, the firm has successfully launched several prominent biotechnology and medtech platforms, including Everest Medicines, AffaMed Therapeutics, and NiKang Therapeutics. With billions of dollars in assets under management, CBC Group is one of the largest and most active healthcare investors in the Asia-Pacific region.